BECN1 and neoplasm: In contrast, ruthenium (II)/allopurinol complex binds to tumor cells to cause DNA damage and upregulate p53 protein, then causing the overexpression of bim, beclin-1 and caspase-3, and ultimately induced cell apoptosis [121].